Explainable AI for Occupational Health Screening
Envisionit Deep AI®’s achieves 510(k) FDA clearance.
“This certification reaffirms Envisionit’s dedication to providing cutting edge technologies that elevate patient care and contribute to improved healthcare outcomes. At Envisionit Deep AI® our commitment to innovation extends beyond just AI solutions, it encompasses ethical considerations and real-time validation as integral components of our mission to advance diagnostic healthcare.” said Dr Jaishree Naidoo, CEO at Envisionit Deep AI®.
Envisionit Deep AI® remains at the forefront of technological advancements in healthcare, continually striving to push the boundaries of what is possible. With a 510(k) FDA clearance in hand, Envisionit Deep AI® is poised to make a lasting impact on the medical imaging diagnostic landscape.
Envisionit Deep AI® remains at the forefront of technological advancements in healthcare, continually striving to push the boundaries of what is possible. With a 510(k) FDA clearance in hand, Envisionit Deep AI® is poised to make a lasting impact on the medical imaging diagnostic landscape.
Explore Radify.ai and it's impact in developing nations
RADIFY AI is transforming how tuberculosis (TB) is detected and managed. Using cutting-edge artificial intelligence, it rapidly analyzes chest X-rays to identify signs of TB and other lung abnormalities with remarkable speed and accuracy and already making a difference in high-burden regions, it’s an essential tool in the global fight against TB.
© 2023, Envisionit Deep AI (Pty) Ltd. 2019/038117/07. All Rights Reserved. Terms & Conditions apply.